Recently, Kamiyama et al. performed N-glycan profile in hepatocellular carcinoma (HCC) using the quantitative N-glycomics procedure by way of glycoblotting technology and using an automated glycan purification system. The study showed significant differences of N-glycans profile between healthy volunteers and liver cancer patients. The glycomic approach showed us the usefulness of new tools for identification and application of a new biomarkers for cancer diagnosis and treatment. These findings reveal a new field for future markers discovery.

Hepatocellular carcinoma markers in the omics era: the glycomic analysis

Malaguarnera, Giulia;Bertino, Gaetano
Conceptualization
;
Vacante, Marco;Malaguarnera, Michele
2014-01-01

Abstract

Recently, Kamiyama et al. performed N-glycan profile in hepatocellular carcinoma (HCC) using the quantitative N-glycomics procedure by way of glycoblotting technology and using an automated glycan purification system. The study showed significant differences of N-glycans profile between healthy volunteers and liver cancer patients. The glycomic approach showed us the usefulness of new tools for identification and application of a new biomarkers for cancer diagnosis and treatment. These findings reveal a new field for future markers discovery.
Hepatocellular carcinoma (HCC)
glycan
glycomic
tumor markers
File in questo prodotto:
File Dimensione Formato  
Hepatocellular carcinoma markers in the omics era.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Dimensione 112.68 kB
Formato Adobe PDF
112.68 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/532179
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact